Our results demonstrated that among the 12 mutated genes, only 3 gene mutations were associated with the prognosis of ccRCC patients significantly, including HMCN1, BAP1, and SYNE1, which were also TMB-related genes (Figure 4A–C). This evidence concerns the gene SYNE1 and nonpapillary renal cell carcinoma.